Q3 Asset Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Q3 Asset Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.03M	Buy	8,698 +5,957	+217%	+$645K	0.19%	51
2026 Q1	$284K	Buy	+2,741	New	+$290K	0.07%	62
2024 Q4	–	Sell	-9,340	Closed	-$812K	–	60
2024 Q3	$812K	Sell	9,340 -4,559	-33%	-$390K	0.19%	34
2024 Q2	$1.14M	Buy	13,899 +285	+2%	+$22.6K	0.26%	28
2024 Q1	$1.09M	Buy	+13,614	New	+$1.05M	0.31%	29
2023 Q3	–	Sell	-13,927	Closed	-$1.05M	–	62
2023 Q2	$1.05M	Buy	+13,927	New	+$1.06M	0.51%	27
2020 Q3	–	Sell	-11,103	Closed	-$718K	–	33
2020 Q2	$718K	Sell	11,103 -9,378	-46%	-$583K	0.69%	18
2020 Q1	$1.15M	Buy	20,481 +9,648	+89%	+$588K	1.18%	16
2019 Q4	$701K	Buy	+10,833	New	+$659K	1.58%	14

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Q3 Asset Management's PJP Position: Q2 2026 in Review

Q3 Asset Management increased its Invesco Pharmaceuticals ETF (PJP) stake by 217% in Q2 2026, buying an estimated $645K and bringing the position to 8,698 shares worth $1.03M. The position accounts for 0.19% of the portfolio, ranked #51.

Q3 Asset Management first reported a position in PJP in Q4 2019 and has held it in 9 quarters since. The position peaked at $1.15M in Q1 2020. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Q3 Asset Management held 8,698 shares of Invesco Pharmaceuticals ETF worth $1.03M as of Q2 2026.
Q3 Asset Management bought 5,957 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $645K.
Invesco Pharmaceuticals ETF made up 0.19% of Q3 Asset Management's portfolio in Q2 2026, its #51 holding.
Q3 Asset Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2019 and has held it in 9 quarters since.
Q3 Asset Management's Invesco Pharmaceuticals ETF position peaked at $1.15M in Q1 2020.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Q3 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.